Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Staley CA"" wg kryterium: Autor


Wyświetlanie 1-19 z 19
Tytuł:
An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: implications for adjuvant treatment.
Autorzy:
Fisher SB
Patel SH
Bagci P
Kooby DA
El-Rayes BF
Staley CA 3rd
Adsay NV
Maithel SK
Fisher, Sarah B
Patel, Sameer H
Bagci, Pelin
Kooby, David A
El-Rayes, Bassel F
Staley, Charles A 3rd
Adsay, N Volkan
Maithel, Shishir K
Pokaż więcej
Źródło:
Cancer (0008543X); Jan2013, Vol. 119 Issue 2, p445-453, 9p
Czasopismo naukowe
Tytuł:
The Effect of Season and Weather on Orthopaedic Trauma: Consult Volume Is Significantly Correlated with Daily Weather.
Autorzy:
Wilson JM; Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Staley CA; Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Boden AL; Emory University School of Medicine, Atlanta, Georgia, USA.
Boissonneault AR; Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Schwartz AM; Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Schenker ML; Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Pokaż więcej
Źródło:
Advances in orthopedics [Adv Orthop] 2018 Sep 02; Vol. 2018, pp. 6057357. Date of Electronic Publication: 2018 Sep 02 (Print Publication: 2018).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.
Autorzy:
Hall WA; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Petrova AV; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Colbert LE; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Hardy CW; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Fisher SB; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Saka B; Department of Pathology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Shelton JW; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Warren MD; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Pantazides BG; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Gandhi K; Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute, Atlanta, GA, USA.
Kowalski J; Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute, Atlanta, GA, USA.
Kooby DA; 1] Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA [2] Atlanta Veterans Affairs Medical Center, Atlanta, GA, USA.
El-Rayes BF; Department of Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Staley CA 3rd; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Volkan Adsay N; Department of Pathology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Curran WJ; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Landry JC; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Maithel SK; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Yu DS; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Pokaż więcej
Źródło:
Oncogene [Oncogene] 2014 Nov 20; Vol. 33 (47), pp. 5450-6. Date of Electronic Publication: 2013 Nov 25.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma/*metabolism
DNA Helicases/*metabolism
Nerve Tissue Proteins/*metabolism
Pancreatic Neoplasms/*metabolism
Adenocarcinoma/mortality ; Adenocarcinoma/surgery ; Adenocarcinoma/therapy ; Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/metabolism ; Chemotherapy, Adjuvant ; DNA Damage/drug effects ; DNA Helicases/genetics ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Genes, Tumor Suppressor/drug effects ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Nerve Tissue Proteins/genetics ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/surgery ; Pancreatic Neoplasms/therapy ; Prognosis ; Treatment Outcome ; Tumor Cells, Cultured ; Gemcitabine
Czasopismo naukowe
Tytuł:
Intensity modulated radiation therapy for retroperitoneal sarcoma: a case for dose escalation and organ at risk toxicity reduction.
Autorzy:
Koshy M; Department of Radiation Oncology Emory Clinic and Emory University 1365 Clifton Road NE A1300 Atlanta GA 30322 USA.
Landry JC
Lawson JD
Staley CA
Esiashvili N
Howell R
Ghavidel S
Davis LW
Pokaż więcej
Źródło:
Sarcoma [Sarcoma] 2003; Vol. 7 (3-4), pp. 137-48.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-19 z 19

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies